Research on the Efficacy of Fecal Microbiota Transplantation and Microbiota in Japanese Children with Ulcerative Colitis.

Research on the Efficacy of Fecal Microbiota Transplantation and Microbiota in Japanese Children with Ulcerative Colitis. - Research on the Efficacy of FMT to the Children with UC

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026485

Enrollment

Registered

2017-03-10

Start date

2016-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

Fecal Microbiota Transplantation(on Day1, 2 and 3, week 2, 3 and 5) after antibiotic pretreatment using amoxicillin 40mg/kg/day, fosfomycin 100mg/kg/day and metronidazole 16mg/kg/day.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with ulcerative colitis diagnosed by ESPGHAN revised Porto Criteria

Exclusion criteria

Exclusion criteria: Patients who may require surgery for massive bleeding, toxic megacolon, or other condition. Patients with infectious colitis. Patients with HBV, HCV, or HIV. Patients who regarded as imappropriate for enrollment by physician.

Design outcomes

Primary

Measure	Time frame
Proportion of patients who improved PUCAI more than 15 and/or acheived remission (PUCAI <10) at week 5.	—

Countries

Japan

Contacts

Public ContactHirotaka Shimizu

National Center for Child Health and Development Division of Gastroenterology

shimizu-h@ncchd.go.jp03-3416-0181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026